Erika Hamilton, Chief Development Officer, Late Phase and Director, Breast Cancer Research Program at Sarah Cannon Research Institute, shared on LinkedIn:
“Breast cancer care has changed dramatically in recent years.
Treatment is more personalized than ever before, and clinical research is creating new possibilities for patients.
For Breast Cancer Awareness Month, I’m answering a few of the most common questions I hear about breast cancer and highlighting the incredible progress being made through clinical research.”
You might be interested in:
NRG-BR002: Metastasis-Directed Ablation Fails to Improve PFS or OS in Oligometastatic Breast Cancer
